当前位置: X-MOL 学术Am. J. Ophthalmol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234.
American Journal of Ophthalmology ( IF 4.1 ) Pub Date : 2022-08-14 , DOI: 10.1016/j.ajo.2022.07.018
Gala Beykin 1 , Laurel Stell 1 , Muhammad Sohail Halim 1 , Mariana Nuñez 1 , Lilia Popova 1 , Bac T Nguyen 1 , Sylvia L Groth 1 , Amy Dennis 1 , Zhongqiu Li 1 , Melissa Atkins 1 , Tom Khavari 1 , Sophia Y Wang 1 , Robert Chang 1 , Ann C Fisher 1 , Yasir J Sepah 1 , Jeffrey L Goldberg 1
Affiliation  

Abstract not available

中文翻译:

短期局部重组人神经生长因子 (rhNGF) 用于青光眼神经增强的 1b 期随机对照研究勘误表:安全性、耐受性和疗效测量结果。Am J Ophthalmol 2022;234:223-234。

摘要不可用
更新日期:2022-08-15
down
wechat
bug